Ersodetug showed target engagement and hypoglycemia reduction trends in phase 3 cHI study but missed primary endpoints in SunRIZE trial.
Huseyin Demirbilek, MD
Advertisement
Hüseyin Demirbilek is a pediatric endocrinologist at Hacettepe University Faculty of Medicine in Ankara, Turkey.
Articles by Huseyin Demirbilek, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Q&A: GLP-1 Receptor Agonists and the Advent of CKM Syndrome, With Lawrence Leiter, MD
2
The HCPFive: Top News for Healthcare Providers from the Week of 06/21
3
Expanding Use of Dupilumab in Pediatric Patients, With Ilona Frieden, MD
4
When the Allergen Is Not What You Expected: 2 Contact Dermatitis Cases
5